Bank of New York Mellon Corp - AVEO PHARMACEUTICALS INC ownership

AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588307. A total of 61 filers reported holding AVEO PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.65 and the average weighting 0.1%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of AVEO PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$803,308
+504.0%
53,733
+232.7%
0.00%
Q3 2022$133,000
+70.5%
16,151
+28.5%
0.00%
Q3 2021$78,000
-42.6%
12,564
-39.0%
0.00%
Q2 2021$136,000
-68.6%
20,584
-65.1%
0.00%
Q1 2021$433,000
+27.7%
59,049
+0.7%
0.00%
Q4 2020$339,000
+9.4%
58,613
+12.3%
0.00%
Q3 2020$310,000
+42.2%
52,213
+23.0%
0.00%
Q2 2020$218,00042,4330.00%
Other shareholders
AVEO PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
NEA Management Company, LLC 3,952,958$23,481,0000.99%
Cormorant Asset Management, LP 1,000,000$5,940,0000.23%
WealthTrust Axiom LLC 22,347$132,0000.06%
SECTORAL ASSET MANAGEMENT INC 100,000$594,0000.05%
Virtu Financial LLC 24,577$146,0000.02%
PDT Partners, LLC 61,839$367,0000.02%
SABBY MANAGEMENT, LLC 26,039$155,0000.02%
MGO ONE SEVEN LLC 10,000$59,0000.01%
WINTON GROUP Ltd 45,208$269,0000.01%
Ancora Advisors LLC 36,350$216,0000.01%
View complete list of AVEO PHARMACEUTICALS INC shareholders